Clarence Machado
Chairman bij ADVERUM BIOTECHNOLOGIES, INC.
Vermogen: 553 415 $ op 31-03-2024
Profiel
Clarence Patrick Machado is the founder of Medivation, Inc. (founded in 1995) and Medivation LLC (California) (founded in 1995).
He held the title of Director at both companies from 2014 to 2016.
Mr. Machado's current job(s) include Chairman at Adverum Biotechnologies, Inc. (since 2017), Independent Director at Chimerix, Inc. (since 2014), Independent Director at Xenon Pharmaceuticals, Inc. (since 2020), Director at Turnstone Biologics, Inc., Independent Director at Arcus Biosciences, Inc. (since 2019), Director at Auransa, Inc., Director at Roivant Sciences, Inc., Director at ACELYRIN, Inc. (since 2021), and Member-Supervisory Board at Therachon Holding GmbH.
Mr. Machado's former job(s) include Chairman at Armaron Bio Ltd., Independent Director at Inotek Pharmaceuticals Corp.
(from 2016 to 2018), Director at Principia Biopharma, Inc. (from 2019 to 2020), Independent Director at Turning Point Therapeutics, Inc. (from 2019 to 2022), Independent Director at Roivant Sciences Ltd.
(from 2016 to 2022), Independent Director at SCYNEXIS, Inc. (from 2015 to 2019), Independent Director at Endocyte, Inc. (in 2018), Chief Financial Officer, Director & Senior VP at Medivation Neurology LLC (from 2003 to 2004), Director at Sio Gene Therapies, Inc. (from 2017 to 2018), Director at Axovant Sciences, Inc. (from 2017 to 2018), Independent Director at Montes Archimedes Acquisition Corp., Independent Director at Turnstone Biologics Corp.
(from 2018 to 2024), Chief Legal Counsel at Chiron Corp., Chief Financial Officer at Orion Acquisition Corp.
II, Consultant at Cytyc Corp.
(in 2002), Principal at Morrison & Foerster LLP, and Chief Financial Officer & Senior Vice President at Pro-Duct Health, Inc. (from 1998 to 2001).
Mr. Machado's education includes an undergraduate degree from Santa Clara University (conferred in 1986) and a graduate degree from Harvard Law School (conferred in 1989).
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ARCUS BIOSCIENCES, INC.
0.02% | 15-06-2023 | 16 900 ( 0.02% ) | 319 072 $ | 31-03-2024 |
09-06-2023 | 8 818 ( 0.04% ) | 124 687 $ | 31-03-2024 | |
ACELYRIN, INC.
0.02% | 04-10-2023 | 14 675 ( 0.02% ) | 99 056 $ | 31-03-2024 |
CHIMERIX, INC.
0.01% | 09-06-2023 | 10 000 ( 0.01% ) | 10 600 $ | 31-03-2024 |
02-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 | |
21-07-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Clarence Machado
Bedrijven | Functie | Begin |
---|---|---|
CHIMERIX, INC. | Director/Board Member | 20-06-2014 |
ADVERUM BIOTECHNOLOGIES, INC. | Chairman | 01-05-2019 |
ARCUS BIOSCIENCES, INC. | Director/Board Member | 10-12-2019 |
XENON PHARMACEUTICALS INC. | Director/Board Member | 05-11-2020 |
ACELYRIN, INC. | Director/Board Member | 01-05-2021 |
Auransa, Inc.
Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | Director/Board Member | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Director/Board Member | - |
Therachon Holding GmbH
Therachon Holding GmbH BiotechnologyHealth Technology Therachon Holding GmbH engages in the acquisition, management, financing, and disposal of participating interests in firms. It also acquires, holds, and disposes intellectual property rights. The company was founded on December 22, 2015 and is headquartered in Basel, Switzerland. | Director/Board Member | - |
Eerdere bekende functies van Clarence Machado
Bedrijven | Functie | Einde |
---|---|---|
TURNSTONE BIOLOGICS CORP. | Director/Board Member | 15-04-2024 |
░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Opleiding van Clarence Machado
Santa Clara University | Undergraduate Degree |
Harvard Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 8 |
---|---|
CHIMERIX, INC. | Health Technology |
ROIVANT SCIENCES LTD. | Health Technology |
XENON PHARMACEUTICALS INC. | Health Technology |
SCYNEXIS, INC. | Health Technology |
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
ARCUS BIOSCIENCES, INC. | Health Technology |
TURNSTONE BIOLOGICS CORP. | Health Technology |
ACELYRIN, INC. | Health Technology |
Bedrijven in privébezit | 19 |
---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Orion Acquisition Corp. II | Finance |
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Health Technology |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
Principia Biopharma, Inc.
Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Morrison & Foerster LLP
Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA. | Commercial Services |
Pro-Duct Health, Inc.
Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Pro·Duct Health manufactures the devices used in ductal lavage. The company is dedicated to eradicating breast cancer by enabling the earliest possible detection of breast pre-cancer and cancer | Health Technology |
Medivation, Inc. /Old/ | Health Technology |
Endocyte, Inc.
Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Medivation Neurology LLC
Medivation Neurology LLC BiotechnologyHealth Technology Part of Pfizer Inc., Medivation Neurology LLC develops and produces biopharmaceutical products. The private company is based in San Francisco, CA. | Health Technology |
Armaron Bio Ltd.
Armaron Bio Ltd. Electronic Equipment/InstrumentsElectronic Technology Armaron Bio Ltd. operates a clinical stage biotechnology firm. It discovers, develops, and commercializes proprietary molecules to prevent heart failure, diabetes, and other serious diseases. The company is headquartered in Melbourne, Australia. | Electronic Technology |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
Auransa, Inc.
Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Therachon Holding GmbH
Therachon Holding GmbH BiotechnologyHealth Technology Therachon Holding GmbH engages in the acquisition, management, financing, and disposal of participating interests in firms. It also acquires, holds, and disposes intellectual property rights. The company was founded on December 22, 2015 and is headquartered in Basel, Switzerland. | Health Technology |
Montes Archimedes Acquisition Corp.
Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Montes Archimedes Acquisition Corp operates as a blank check company. It is formed for the business purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded James C. Momtazee and Maria C. Walker on July 6, 2020 and is headquartered in Menlo Park, CA. | Finance |